tab lenalidomide 10mg,trifluridine plus tipiracil 20mg plus 8 deci 19 mg,dihydralazine 25mg,tab ten
Other · open
Key facts
- Closing date: 01 Aug 2026
- Status: open
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
Commercial terms
- Make in India (MII): No
- MSE preference: No
1 tender document(s) available — sign up to download.